Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikhil Joshi

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Neuro-Oncology|May 24, 2025
Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high grade glioma modelsJessica B Foster, Peter J Madsen, Kyra Harvey, et al.
Journal of the American Heart Association|September 14, 2022
Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID-19Shirjel R Alam, Sudhir Vinayak, Adeel Shah, et al.
Journal for Immunotherapy of Cancer|January 4, 2023
Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosisLauren M Perry, Sylvia M Cruz, Kara T Kleber, et al.
Acta Neuropathologica Communications|August 10, 2024
Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progressionJohn R Apps, Jose Mario Gonzalez-Meljem, Romain Guiho, et al.
Cancer Discovery|December 6, 2022
Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic CancerSamantha B Kemp, Noah Cheng, Nune Markosyan, et al.
JACC. Cardiovascular Imaging|February 26, 2022
Bypass Grafting and Native Coronary Artery Disease ActivityJacek Kwiecinski, Evangelos Tzolos, Alexander J Fletcher, et al.
Journal for Immunotherapy of Cancer|October 10, 2025
Claudin 6 is a suitable target for CAR T-cell therapy in atypical teratoid/rhabdoid brain tumors and other pediatric solid tumorsPeter J Madsen, Anna Melissa Schlitter, Carina Flemmig, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Neuro-Oncology|May 24, 2025
Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high grade glioma modelsJessica B Foster, Peter J Madsen, Kyra Harvey, et al.
Journal of the American Heart Association|September 14, 2022
Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID-19Shirjel R Alam, Sudhir Vinayak, Adeel Shah, et al.
Journal for Immunotherapy of Cancer|January 4, 2023
Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosisLauren M Perry, Sylvia M Cruz, Kara T Kleber, et al.
Acta Neuropathologica Communications|August 10, 2024
Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progressionJohn R Apps, Jose Mario Gonzalez-Meljem, Romain Guiho, et al.
Cancer Discovery|December 6, 2022
Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic CancerSamantha B Kemp, Noah Cheng, Nune Markosyan, et al.
JACC. Cardiovascular Imaging|February 26, 2022
Bypass Grafting and Native Coronary Artery Disease ActivityJacek Kwiecinski, Evangelos Tzolos, Alexander J Fletcher, et al.
Journal for Immunotherapy of Cancer|October 10, 2025
Claudin 6 is a suitable target for CAR T-cell therapy in atypical teratoid/rhabdoid brain tumors and other pediatric solid tumorsPeter J Madsen, Anna Melissa Schlitter, Carina Flemmig, et al.
Pageof 11